Browse > Article
http://dx.doi.org/10.4333/KPS.2010.40.4.255

Physiochemical Properties of Binary Pluronic Systems for Reversal of Multi-drug Resistant (MDR) Cancers  

Yun, Jung-Min (College of Pharmacy, Chung-Ang University)
Park, Ga-Young (College of Pharmacy, Chung-Ang University)
Kim, Ha-Hyung (College of Pharmacy, Chung-Ang University)
Lee, Jae-Hwi (College of Pharmacy, Chung-Ang University)
Lee, Eun-Seong (Division of Biotechnology, The Catholic University of Korea)
Youn, Yu-Seok (College of Pharmacy, Pusan National University)
Lee, Beom-Jin (Bioavailability Control Laboratory, College of Pharmacy, Kangwon National University)
Oh, Young-Taik (Department of Diagnostic Radiology, Research Institute of Radiological Science, College of Medicine, Yonsei University)
Oh, Kyung-Taek (College of Pharmacy, Chung-Ang University)
Publication Information
Journal of Pharmaceutical Investigation / v.40, no.4, 2010 , pp. 255-261 More about this Journal
Abstract
Pluronic as pharmaceutical excipients are listed in the US and British Pharmacopoeia. In particular, Pluronics exist as different compositions and display abundant phases as self-assembling into polymeric micelles with various morphologies depending on the aqueous solvent quality, the composition of structure, and hydrophilic-lipophilic balance (HLB). Pluronics were also known as a P-gp modulator, which was exploited as a reversal molecule of multi-drug resistant (MDR) cancers. We selected a lamella forming Pluronic L92 which has high hydrophobicity and relatively long PEO block among L series of Pluronics. The dispersion of L92 showed great size particles and low stability. To increase the stability and to decrease the particle size, secondary Pluronics (F68, F88, F98, F127, P85, P105, and P123) with relatively long PEO chain were added into 0.1 wt% Pluronic L92 dispersion. The stability of binary systems was increased due to incorporated long PEO chain. Their particle sizes slightly decreased to over 200~400 nm and their solubilization capacity of binary systems didn't change except Pluronic L92/P123 mixtures. The L92/P123 systems showed ca. 100 nm sizes and lowest turbidity among the all systems. The solubilization capacity of 0.1 wt% L92/0.1 wt% P123 was slightly increased compared to 0.1 wt% L92 mono system and other binary systems. These nano-sized binary systems may have potential as alternative drug delivery systems with simple preparation method and overcome the drawbacks of mono systems such as low stability and loading capacity.
Keywords
Pluronic; binary system; nanosized; MDR; drug delivery system; solubilization;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lee, E.S., Shin, H.J., Na, K., Bae, Y.H., 2003. Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J Control Release. 90, 363-74.   DOI
2 Nagarajan, R., 1999. Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic?(PEO-PPO-PEO) block copolymers. Colloids and Surfaces B: Biointerfaces. 16, 55-72.   DOI
3 Oh, K.T., Bronich, T.K., Kabanov, A.V., 2004. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers. J Control Release. 94, 411-22.   DOI
4 Oh, K.T., Lee, E.S., Kim, D., Bae, Y.H., 2008. L-histidine-based pH-sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity. Int J Pharm. 358, 177-83.   DOI
5 Torchilin, V.P., 1999. Polymeric micelles in diagnostic imaging. Colloids and Surfaces B: Biointerfaces. 16, 305-319.   DOI
6 Wang, Y., Yu, L., Han, L., Sha, X., Fang, X., 2007. Difunctional Pluronic copolymer micelles for paclitaxel delivery: Synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. International Journal of Pharmaceutics. 337, 63-73.   DOI
7 Chaibundit, C., Ricardo, N.M.P.S., Costa, F.d.M.L.L., Yeates, S.G., Booth, C., 2007. Micellization and Gelation of Mixed Copolymers P123 and F127 in Aqueous Solution. Langmuir. 23, 9229-9236.   DOI
8 Gaisford, S., Beezer, A.E., Mitchell, J.C., 1997. Diode-Array UV Spectrometric Evidence for Cooperative Interactions in Binary Mixtures of Pluronics F77, F87, and F127. Langmuir. 13, 2606-2607.   DOI
9 Kabanov, A.V., Alakhov, V.Y., 2002. Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit. Rev. Ther. Drug Carrier Syst. 19, 1-72.   DOI
10 Kabanov, A.V., Batrakova, E.V., Alakhov, V.Y., 2002. Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev. 54, 759-79.   DOI
11 Kataoka, K., Kabanov, A., Eds. (1999). Special Issue: Polymeric Micelles in Biology and Pharmaceutics, Colloids and Surfaces, B: Biointerfaces. Amsterdam, Lausanne, New York, Oxford, Shannon, Tokyo, Elsevier.
12 Lee, E.S., Na, K., Bae, Y.H., 2005. Super pH-sensitive multi-functional polymeric micelle. Nano Lett. 5, 325-9.   DOI
13 Kozlov, M.Y., Melik-Nubarov, N.S., Batrakova, E.V., Kabanov, A.V., 2000. Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes. Macromolecules. 33, 3305-3313.   DOI   ScienceOn
14 Kwon, G.S., Kataoka, K., 1995. Block copolymer micelles as long-circulating drug vehicles. Advanced Drug Delivery Reviews. 16, 295-309.   DOI
15 Langer, R., 1998. Drug delivery and targeting. Nature. 392, 5-10.
16 Lee, E.S., Oh, Y.T., Youn, Y.S., Nam, M., Park, B., Yun, J., Kim, J.H., Song, H.-T., Oh, K.T., 2010. Binary mixing of micelles using Pluronics for a nanosized drug delivery system Colloids and Surfaces B: Biointerfaces. in submission.
17 Alakhov, V., Klinski, E., Lemieux, P., Pietrzynski, G., Kabanov, A., 2001. Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Opinion on Biological Therapy. 1, 583-602.   DOI
18 Alakhov, V., Klinski, E., Li, S., Pietrzynski, G., Venne, A., Batrakova, E., Bronitch, T., Kabanov, A.V., 1999. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloids Surf., B: Biointerfaces. 16, 113-134.   DOI
19 Allen, C., Maysinger, D., Eisenberg, A., 1999. Nano-engineering block copolymer aggregates for drug delivery. Colloids and Surfaces B: Biointerfaces. 16, 3-27.   DOI   ScienceOn
20 Allison, A.C., Byars, N.E., 1986. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J. Immunol. Methods. 95, 157-168.   DOI
21 Batrakova, E.V., Lee, S., Li, S., Venne, A., Alakhov, V., Kabanov, A., 1999b. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm. Res. 16, 1373-1379.   DOI
22 Allison, A.C., Byars, N.E., 1990. Adjuvant formulations and their mode of action. Semin. Immunol. 2, 369-374.
23 BASF Pluronic and Tetronic Surfactants. Wyandotte, BASF Corp.
24 Batrakova, E., Lee, S., Li, S., Venne, A., Alakhov, V., Kabanov, A., 1999a. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res. 16, 1373-9.   DOI
25 Batrakova, E.V., Miller, D.W., Li, S., Alakhov, V.Y., Kabanov, A.V., Elmquist, W.F., 2001. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. J. Pharmacol. Exp. Ther. 296, 551-557.